<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02485444</url>
  </required_header>
  <id_info>
    <org_study_id>2015-80</org_study_id>
    <nct_id>NCT02485444</nct_id>
  </id_info>
  <brief_title>Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion</brief_title>
  <official_title>Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage Management After Second-trimester Abortion: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares oxytocin infusion to spontaneous follow-up for third-stage of labor at
      induced mid-trimester abortions. Patients will be randomized to oxytocin infusion or
      observation with no pharmacologic intervention. Primary outcome of the study is complete
      abortion rate within two hours of fetal delivery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete abortion rate</measure>
    <time_frame>within 5 minute after placenta delivered</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss estimated by gravimetric method</measure>
    <time_frame>within 10 minutes after delivery of placenta</time_frame>
    <description>blood loss will be estimated by gravimetric method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion rate</measure>
    <time_frame>Within 7 days of hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin measured by difference in hemoglobin before and 24-hour after abortion</measure>
    <time_frame>24 hours after delivery of placenta</time_frame>
    <description>Difference in hemoglobin before and 24-hour after abortion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placenta delivery time measured by time elapsed until the delivery of the placenta from the delivery of foetus</measure>
    <time_frame>5 minute after delivery of placenta</time_frame>
    <description>The time elapsed until the delivery of the placenta from the delivery of foetus</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Abortion, Induced</condition>
  <condition>Labor Stage, Third/Drug Effects</condition>
  <condition>Pregnancy Trimester, Second</condition>
  <condition>Oxytocin/Administration &amp; Dosage</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>20 IU oxytocin in 500 ml normal saline will be infused 100 ml/h i.v. after fetus is delivered</description>
    <arm_group_label>Oxytocin</arm_group_label>
    <other_name>Synpitan</other_name>
    <other_name>Pitocin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Women who had mid-trimester termination of pregnancy between 13-24 gestational weeks

        Exclusion Criteria:

          -  If fetus and placenta expelled together

          -  Obstetrical haemorrhage needs intervention

          -  Known prostaglandin allergy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omer E Yapca, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ataturk University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ragıp A AL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ataturk University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ragıp A AL, MD</last_name>
    <phone>00903447649</phone>
    <email>atakanal@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Atatürk Üniversitesi Araştırma Hastanesi</name>
      <address>
        <city>Erzurum</city>
        <zip>25240</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ragıp A AL, MD</last_name>
      <phone>00903447649</phone>
    </contact>
    <contact_backup>
      <last_name>Ömer E Yapça</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2015</study_first_submitted>
  <study_first_submitted_qc>June 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2015</study_first_posted>
  <last_update_submitted>July 3, 2015</last_update_submitted>
  <last_update_submitted_qc>July 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ragıp Atakan Al</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

